Member Info for Kilgeever

A fine week ahead.

Malafuster auto correct.
Sorry.
An inappropriate error..

But only when logged in.
Oil is doing well ATM. As Maladjusted says, nearing 75$.
Any attempt to be as destructive as a head of state has failed.

Imaginary stuff created by a particular poster. That's goolagong factor. I have it filtered.

Gtld. Too optimistic.

Hopefully PMO related information is more accurate.
Regards
Pedant

Squid and other cephalopods may indeed be damp owing to habitat.
Has little to do with expectation being less than reality.
Squib: a type of firework. Thus a damp one fails to ignite.
Why the need to correct? Simple.
I prefer to trust what I read. Get this wrong and what else?

Accumulation in progress.

I'm looking at the figures, irrelevant though they are... mentally the 130 figure seems to be an obstacle. But not for GKP. That's all. Many holders regard particular numbers as significant whether or not they are support or technical resistance. The psychological resistance is very powerful.

3 months ago GKP Sp same as PMO is today. Yes, I know the difference between sp and mcap. Regardless, GKP seems to have doubled in three months, working in a politically difficult region compared with NSea etc. Just dreaming.

Nm

Perhaps forthcoming entry might reduce the volatility where minor changes in PoO result in disproportionate moves in SP. Clearly this morning's relatively gentle moves are still excessive. Still being played!

18 months ago successful phase 2 could mean licencing deals or takeover. Well, Phase 2 has proven successful ( within remit and sectoral standard) so certainly less risky and potential for significant upside. "Evgen believes its Sulforadex technology fixes the problem, thus unlocking the commercial benefits provided by the compound. If it is right then success could translate into a licensing deal with significant milestone payments and eventually royalties if the drugs successfully pass phase III trials. If it is wrong the share price will likely crash. There is also the possibility that successful phase II trials could prompt a takeover bid from a larger player looking to own the Sulforadex technology and generate a pipeline of similar treatments".

Nm

Get used to these shakes..after really encouraging news the fundamentals are better than ever. Would like to top up under 20 but I'm broke.

£22k traded, 88k shares. 14% fall.. Again! And after 2 positive announcements. AIM. So no surprise

A market cap of �100m it would still be considered small with the potential it has. Of course risk remains but must be worth a punt for a larger pharmaceutical company. Holy Grail etc

Mcap of c�20m About 100m shares Those are seriously low figures and the interim result today is hugely significant. The eyes of the related medical companies will be looking very carefully at the company. Mcap is small fry/ peanuts/ petty cash for big pharma looking at the potential. Huge.

The news had been bad!

On 186k shares. That's a huge swing on �40k traded. Should correct before long.... today or tomorrow